MedKoo Cat#: 341242 | Name: Yomogin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Yomogin is a biochemical.

Chemical Structure

Yomogin
Yomogin
CAS#10067-18-2

Theoretical Analysis

MedKoo Cat#: 341242

Name: Yomogin

CAS#: 10067-18-2

Chemical Formula: C15H16O3

Exact Mass: 244.1099

Molecular Weight: 244.29

Elemental Analysis: C, 73.75; H, 6.60; O, 19.65

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Yomogin
IUPAC/Chemical Name
2-Naphthaleneacetic acid, 1,2beta,3,4,4a,7-hexahydro-3alpha-hydroxy-4aalpha,8-dimethyl-alpha-methylene-7-oxo-, gamma-lactone
InChi Key
ONPJVBQNWRHOKG-WDBKCZKBSA-N
InChi Code
InChI=1S/C15H16O3/c1-8-10-6-11-9(2)12(16)4-5-15(11,3)7-13(10)18-14(8)17/h4-5,10,13H,1,6-7H2,2-3H3/t10-,13-,15-/m1/s1
SMILES Code
O=C(O[C@H]1[C@@H]2CC3=C(C)C(C=C[C@]3(C)C1)=O)C2=C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 244.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Natividad GM, Broadley KJ, Kariuki B, Kidd EJ, Ford WR, Simons C. Actions of Artemisia vulgaris extracts and isolated sesquiterpene lactones against receptors mediating contraction of guinea pig ileum and trachea. J Ethnopharmacol. 2011 Sep 1;137(1):808-16. doi: 10.1016/j.jep.2011.06.042. Epub 2011 Jul 5. PubMed PMID: 21762766. 2: Jeong SH, Koo SJ, Ha JH, Ryu SY, Park HJ, Lee KT. Induction of apoptosis by yomogin in human promyelocytic leukemic HL-60 cells. Biol Pharm Bull. 2004 Jul;27(7):1106-11. PubMed PMID: 15256749. 3: Kim SH, Kim TS. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps. Planta Med. 2002 Oct;68(10):886-90. PubMed PMID: 12391550. 4: Tigno XT, de Guzman F, Flora AM. Phytochemical analysis and hemodynamic actions of Artemisia vulgaris L. Clin Hemorheol Microcirc. 2000;23(2-4):167-75. PubMed PMID: 11321437. 5: Tigno XT, Gumila E. In vivo microvascular actions of Artemisia vulgaris L. in a model of ischemia-reperfusion injury in the rat intestinal mesentery. Clin Hemorheol Microcirc. 2000;23(2-4):159-65. PubMed PMID: 11321436. 6: Ryu SY, Oak MH, Kim KM. Yomogin inhibits the degranulation of mast cells and the production of the nitric oxide in activated RAW 264.7 cells. Planta Med. 2000 Mar;66(2):171-3. PubMed PMID: 10763594. 7: Ryu JH, Lee HJ, Jeong YS, Ryu SY, Han YN. Yomogin, an inhibitor of nitric oxide production in LPS-activated macrophages. Arch Pharm Res. 1998 Aug;21(4):481-4. PubMed PMID: 9875481.